CQuIPS Symposium 2024: Afternoon Plenary - Muhammad Mamdani
Watch video from the CQuIPS Symposium 2024 afternoon plenary session “Applied Artificial Intelligence in Healthcare: Implications for Clinical Practice and Quality Improvement”
Presentation overview:
Artificial intelligence (AI) is expected to transform healthcare but adoption has been slow. Health AI literacy and education will be critical to the successful adoption of AI in healthcare. This session will review the experience of Unity Health Toronto in developing and deploying over 50 machine-learned solutions into clinical practice with clear examples of initiatives with tangible patient and productivity outcomes. The session will review the promise and challenges of pragmatically developing and deploying AI solutions in clinical practice.
Speaker Biography:
Muhammad Mamdani is Vice President of Data Science and Advanced Analytics at Unity Health Toronto and Director of U of T’s Temerty Faculty of Medicine Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM). Dr. Mamdani’s team bridges advanced analytics including machine learning with clinical and management decision making to improve patient outcomes and hospital efficiency with over 50 AI solutions developed and deployed into clinical practice. Dr. Mamdani is also Professor in the Department of Medicine of the Temerty Faculty of Medicine, the Leslie Dan Faculty of Pharmacy, and the Institute of Health Policy, Management and Evaluation of the Dalla Lana School of Public Health. He is also Affiliate Scientist at IC/ES and a Faculty Affiliate of the Vector Institute, which is a leading institution for artificial intelligence research in Canada. Further, Dr. Mamdani is a member of the Human Drug Advisory Panel of the Patented Medicine Prices Review Board (PMPRB). Previously, Dr. Mamdani founded the Ontario Drug Policy Research Network (ODPRN), which is among the world’s most impactful collaborations between researchers and drug policy decision-makers. He was also the Founding Director of the Li Ka Shing Centre for Healthcare Analytics Research and Training (LKS-CHART) of Unity Health Toronto and the Founding Director of the Applied Health Research Centre (AHRC) of the Li Ka Shing Knowledge Institute of Unity Health Toronto, which is Toronto’s leading academic research organization focused on the design and implementation of multicentre clinical research initiatives including large randomized clinical trials. In 2010, Dr. Mamdani was named among Canada’s Top 40 under 40. Prior to joining the Li Ka Shing Knowledge Institute and Unity Health Toronto, Dr. Mamdani was a Director of Outcomes Research at Pfizer Global Pharmaceuticals in New York. Dr. Mamdani’s research interests include pharmacoepidemiology, pharmacoeconomics, drug policy, and the application of advanced analytics approaches to clinical problems and health policy decision-making. He has published over 500 research studies in peer-reviewed medical journals, including leading journals such as the New England Journal of Medicine, the Lancet, the Journal of the American Medical Association, the British Medical Journal, and Annals of Internal Medicine. His research has been cited over 45,000 times and has an h-index of over 100.
